Magnetism and spin dynamics of novel encapsulated iron oxide superparamagnetic nanoparticles.

Encapsulated Fe3O4 nanoparticles of average diameters d = 12 nm are obtained by coprecipitation, in the presence of 2-methoxyethanol hemiester of poly(maleic anhydride-alt-butyl vinyl ether) 5% grafted with poly(ethylene glycol) (VP-MAG nanoparticles). A complete characterization of nude and encapsulated nanoparticles through structural techniques (namely XRD, TEM, SEM), Raman spectroscopy and magnetic measurements has been performed. These nanoparticles compared with commercial compounds (ENDOREM®) present superparamagnetic behavior and nuclear relaxivities that make them promising as magnetic resonance imaging (MRI) contrast agents (CAs). We found that our nanostructures exhibit r2 relaxivity higher than those of commercial CAs over the whole frequency range. The MRI efficiency of our samples was related to their microstructural and magnetic properties.

[1]  C. Innocenti,et al.  Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties. , 2011, Journal of the American Chemical Society.

[2]  Wolfgang Tremel,et al.  Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment. , 2011, Dalton transactions.

[3]  Wen-Yen Huang,et al.  Multimodality and nanoparticles in medical imaging. , 2011, Dalton transactions.

[4]  F. Chiellini,et al.  Hemoglobin loaded polymeric nanoparticles: preparation and characterizations. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  S. Ferrari,et al.  Phase stability and homogeneity in undoped and Mn‐doped LiFePO4 under laser heating , 2010 .

[6]  A. S. Moses,et al.  Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.

[7]  C. Innocenti,et al.  Magnetic Resonance Imaging Contrast Agents Based on Iron Oxide Superparamagnetic Ferrofluids , 2010 .

[8]  Bernadette Erokwu,et al.  Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. , 2009, Biomaterials.

[9]  A. Caneschi,et al.  Water-soluble rhamnose-coated Fe3O4 nanoparticles. , 2009, Organic letters.

[10]  Chenjie Xu,et al.  Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applications. , 2009, Dalton transactions.

[11]  Zahi A Fayad,et al.  Nanotechnology in Medical Imaging: Probe Design and Applications , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Siddiq,et al.  Human serum albumin unfolding pathway upon drug binding: A thermodynamic and spectroscopic description , 2009 .

[13]  Harald Ittrich,et al.  Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals. , 2009, Nature nanotechnology.

[14]  A. Lascialfari,et al.  MRI relaxation properties of water-soluble apoferritin-encapsulated gadolinium oxide-hydroxide nanoparticles. , 2009, Dalton transactions.

[15]  L. Tei,et al.  Paramagnetic Liposomes as Innovative Contrast Agents for Magnetic Resonance (MR) Molecular Imaging Applications , 2008, Chemistry & biodiversity.

[16]  A. Lascialfari,et al.  Cyano-bridged coordination polymer nanoparticles with high nuclear relaxivity: toward new contrast agents for MRI. , 2008, Dalton transactions.

[17]  C. Innocenti,et al.  Magnetic and relaxometric properties of Mn ferrites , 2008 .

[18]  C. Sangregorio,et al.  Magnetic properties of novel superparamagnetic MRI contrast agents based on colloidal nanocrystals , 2008 .

[19]  E. Chiellini,et al.  Bioactive polymeric materials for targeted administration of active agents: synthesis and evaluation. , 2008, Macromolecular bioscience.

[20]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[21]  E. Chiellini,et al.  A new biocompatible nanoparticle delivery system for the release of fibrinolytic drugs. , 2008, International journal of pharmaceutics.

[22]  Ichiro Kawahara,et al.  Potential of magnetic resonance plaque imaging using superparamagnetic particles of iron oxide for the detection of carotid plaque. , 2008, Neurologia medico-chirurgica.

[23]  Roberto Cingolani,et al.  One-pot synthesis and characterization of size-controlled bimagnetic FePt-iron oxide heterodimer nanocrystals. , 2008, Journal of the American Chemical Society.

[24]  Biplab Das,et al.  Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. , 2007, Angewandte Chemie.

[25]  F. Chiellini,et al.  Bioeliminable polymeric nanoparticles for proteic drug delivery. , 2007, International journal of pharmaceutics.

[26]  Oliver T. Bruns,et al.  Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. , 2007, Nano letters.

[27]  Dieter Braun,et al.  Size determination of (bio)conjugated water-soluble colloidal nanoparticles : A comparison of different techniques , 2007 .

[28]  I. Chernyshova,et al.  Size-dependent structural transformations of hematite nanoparticles. 1. Phase transition. , 2007, Physical chemistry chemical physics : PCCP.

[29]  Anna Roig,et al.  Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[30]  Liberato Manna,et al.  Synthesis, properties and perspectives of hybrid nanocrystal structures. , 2006, Chemical Society reviews.

[31]  F. Gazeau,et al.  Controlled clustering of superparamagnetic nanoparticles using block copolymers: design of new contrast agents for magnetic resonance imaging. , 2005, Journal of the American Chemical Society.

[32]  Jinwoo Cheon,et al.  Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling. , 2005, Journal of the American Chemical Society.

[33]  Jinwoo Cheon,et al.  Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. , 2005, Journal of the American Chemical Society.

[34]  M. López-López,et al.  Preparation and sedimentation behavior in magnetic fields of magnetite-covered clay particles. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[35]  G. Burns,et al.  Infrared- and Raman-active phonons of magnetite, maghemite, and hematite: a computer simulation and spectroscopic study. , 2005, The journal of physical chemistry. B.

[36]  O. Shebanova,et al.  Raman study of magnetite (Fe3O4): laser‐induced thermal effects and oxidation , 2003 .

[37]  R. Skomski.  TOPICAL REVIEW: Nanomagnetics , 2003 .

[38]  J. Honig,et al.  Raman study of stoichiometric and Zn-doped Fe 3 O 4 , 2002 .

[39]  Ralph Weissleder,et al.  Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. , 2002, Academic radiology.

[40]  S A Wickline,et al.  Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.

[41]  R. Dey,et al.  SPEED OF SOUND, VISCOSITY AND REFRACTIVE INDEX OF MULTICOMPONENT SYSTEMS :THEORETICAL PREDICTIONS FROM THE PROPERTIES OF PURE COMPONENTS , 1999 .

[42]  P. Mergo,et al.  MRI in focal liver disease: A comparison of small and ultra‐small superparamagnetic iron oxide as hepatic contrast agents , 1998, Journal of magnetic resonance imaging : JMRI.

[43]  Dalva Lúcia Araújo de Faria,et al.  Raman microspectroscopy of some iron oxides and oxyhydroxides , 1997 .

[44]  Emo Chiellinia,et al.  New polymeric hydrogel formulations for the controlled release of α-interferon , 1992 .

[45]  A. Lascialfari,et al.  NMR-MRI, μSR and Mössbauer spectroscopies in molecular magnets , 2007 .

[46]  S. Sykora,et al.  TECHNICAL ASPECTS OF FAST FIELD CYCLING , 2005 .